Literature DB >> 9131634

Nonclassical and endogenous cannabinoids: effects on the ordering of brain membranes.

A S Bloom1, W S Edgemond, J C Moldvan.   

Abstract

The effects of several nonclassical cannabinoids and the endogenous cannabinoid ligand, anandamide on the lipid ordering of rat brain synaptic plasma membranes (SPM) were examined and compared to delta 9-tetrahydrocannabinol (delta 9-THC). SPM order was determined using fluorescence polarization. All compounds tested affected membrane ordering. delta 9-THC, CP-55,940, CP-55,244 and WIN-55212 decreased lipid ordering in SPM. Some stereospecificity was observed with delta 9-THC and WIN-55212, but not other compounds. Anandamide also decreased lipid order as did its putative precursor, arachidonic acid. In contrast to these compounds, levonantradol increased SPM lipid order. Although all pharmacologically active cannabinoids affect SPM lipid order, potency on this measure does not correlate well with their pharmacological potency. The results of this study suggest that membrane perturbation (either increases or decreases in lipid order) may be a necessary characteristic for cannabinoid pharmacological activity, but it is not a primary or sufficient determinate of action for this class of drugs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9131634     DOI: 10.1023/a:1022413901857

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  29 in total

1.  Correlation between the psychotropic potency of cannabinoids and their effect on the 1H-NMR spectra of model membranes.

Authors:  I Tamir; D Lichtenberg
Journal:  J Pharm Sci       Date:  1983-04       Impact factor: 3.534

2.  Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency.

Authors:  B F Thomas; D R Compton; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1990-11       Impact factor: 4.030

3.  Studies of the role of membrane lipid order in the effects of delta 9-tetrahydrocannabinol on adenylate cyclase activation in heart.

Authors:  C J Hillard; J J Pounds; D R Boyer; A S Bloom
Journal:  J Pharmacol Exp Ther       Date:  1990-03       Impact factor: 4.030

4.  Determination and characterization of a cannabinoid receptor in rat brain.

Authors:  W A Devane; F A Dysarz; M R Johnson; L S Melvin; A C Howlett
Journal:  Mol Pharmacol       Date:  1988-11       Impact factor: 4.436

Review 5.  Cannabinoid pharmacology.

Authors:  W L Dewey
Journal:  Pharmacol Rev       Date:  1986-06       Impact factor: 25.468

6.  Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements.

Authors:  W J Van Blitterswijk; R P Van Hoeven; B W Van der Meer
Journal:  Biochim Biophys Acta       Date:  1981-06-22

7.  Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent.

Authors:  E Fride; R Mechoulam
Journal:  Eur J Pharmacol       Date:  1993-02-09       Impact factor: 4.432

8.  Amphipathic interactions of cannabinoids with membranes. A comparison between delta 8-THC and its O-methyl analog using differential scanning calorimetry, X-ray diffraction and solid state 2H-NMR.

Authors:  D P Yang; T Mavromoustakos; K Beshah; A Makriyannis
Journal:  Biochim Biophys Acta       Date:  1992-01-10

9.  Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents.

Authors:  D R Compton; M R Johnson; L S Melvin; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1992-01       Impact factor: 4.030

10.  Cannabinoid receptor localization in brain.

Authors:  M Herkenham; A B Lynn; M D Little; M R Johnson; L S Melvin; B R de Costa; K C Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

View more
  5 in total

Review 1.  The pharmacology of the cannabinoid system--a question of efficacy and selectivity.

Authors:  Christopher J Fowler
Journal:  Mol Neurobiol       Date:  2007-07-07       Impact factor: 5.590

2.  Effects of Delta9-tetrahydrocannabivarin on [35S]GTPgammaS binding in mouse brain cerebellum and piriform cortex membranes.

Authors:  I Dennis; B J Whalley; G J Stephens
Journal:  Br J Pharmacol       Date:  2008-05-19       Impact factor: 8.739

3.  The phytocannabinoid Delta(9)-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum.

Authors:  Y-L Ma; S E Weston; B J Whalley; G J Stephens
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

4.  The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets.

Authors:  Torsten Lowin; Georg Pongratz; Rainer H Straub
Journal:  J Inflamm (Lond)       Date:  2016-05-05       Impact factor: 4.981

5.  Role of pannexin-1 in the cellular uptake, release and hydrolysis of anandamide by T84 colon cancer cells.

Authors:  Mireille Alhouayek; René Sorti; Jonathan D Gilthorpe; Christopher J Fowler
Journal:  Sci Rep       Date:  2019-05-20       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.